JP2005504042A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005504042A5 JP2005504042A5 JP2003518536A JP2003518536A JP2005504042A5 JP 2005504042 A5 JP2005504042 A5 JP 2005504042A5 JP 2003518536 A JP2003518536 A JP 2003518536A JP 2003518536 A JP2003518536 A JP 2003518536A JP 2005504042 A5 JP2005504042 A5 JP 2005504042A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- alkylene
- aryl
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 79
- 150000001875 compounds Chemical class 0.000 claims 39
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 30
- 125000001072 heteroaryl group Chemical group 0.000 claims 14
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 125000003118 aryl group Chemical group 0.000 claims 12
- 125000002947 alkylene group Chemical group 0.000 claims 11
- 125000005843 halogen group Chemical group 0.000 claims 10
- 150000002367 halogens Chemical class 0.000 claims 10
- 229910052757 nitrogen Inorganic materials 0.000 claims 10
- 229910052736 halogen Inorganic materials 0.000 claims 8
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 6
- 125000003107 substituted aryl group Chemical group 0.000 claims 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- FUFZNHHSSMCXCZ-UHFFFAOYSA-N 5-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole Chemical group FC(F)(F)C1=CC=CC(C=2N=C(ON=2)C2CCNCC2)=C1 FUFZNHHSSMCXCZ-UHFFFAOYSA-N 0.000 claims 3
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 claims 2
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 claims 2
- 102000013455 Amyloid beta-Peptides Human genes 0.000 claims 2
- 108010090849 Amyloid beta-Peptides Proteins 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 230000008021 deposition Effects 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 230000005764 inhibitory process Effects 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 230000004770 neurodegeneration Effects 0.000 claims 2
- 208000015122 neurodegenerative disease Diseases 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 210000001061 forehead Anatomy 0.000 claims 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- KVNTYWJXYWVWAF-UHFFFAOYSA-N COC(c1ccc(CN(C(CCC2)CN2C(Cc2cccnc2)=O)S(c(cc2)ccc2Cl)(=O)=O)cc1)=O Chemical compound COC(c1ccc(CN(C(CCC2)CN2C(Cc2cccnc2)=O)S(c(cc2)ccc2Cl)(=O)=O)cc1)=O KVNTYWJXYWVWAF-UHFFFAOYSA-N 0.000 description 1
- IONZKRNFSCBNTA-UHFFFAOYSA-N COC(c1ccc(CN(C(CCC2)CN2C(N2CCCC2)=O)S(c(cc2)ccc2Cl)(=O)=O)cc1)=O Chemical compound COC(c1ccc(CN(C(CCC2)CN2C(N2CCCC2)=O)S(c(cc2)ccc2Cl)(=O)=O)cc1)=O IONZKRNFSCBNTA-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31006801P | 2001-08-03 | 2001-08-03 | |
| PCT/US2002/024293 WO2003013527A1 (en) | 2001-08-03 | 2002-08-01 | Sulfonamide derivatives as gamma secretase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005504042A JP2005504042A (ja) | 2005-02-10 |
| JP2005504042A5 true JP2005504042A5 (cg-RX-API-DMAC7.html) | 2006-01-05 |
Family
ID=23200871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003518536A Pending JP2005504042A (ja) | 2001-08-03 | 2002-08-01 | γセクレターゼインヒビターのようなスルホンアミド誘導体 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7122675B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1411944A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005504042A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1780621A (cg-RX-API-DMAC7.html) |
| AR (1) | AR035260A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2455861A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04001016A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003013527A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6984522B2 (en) | 2000-08-03 | 2006-01-10 | Regents Of The University Of Michigan | Isolation and use of solid tumor stem cells |
| US8044259B2 (en) | 2000-08-03 | 2011-10-25 | The Regents Of The University Of Michigan | Determining the capability of a test compound to affect solid tumor stem cells |
| EP1411944A1 (en) * | 2001-08-03 | 2004-04-28 | Schering Corporation | Sulfonamide derivatives as gamma secretase inhibitors |
| AU2002367147A1 (en) | 2001-12-27 | 2003-07-15 | Daiichi Pharmaceutical Co., Ltd. | Beta-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS |
| GB0223039D0 (en) * | 2002-10-04 | 2002-11-13 | Merck Sharp & Dohme | Therapeutic compounds |
| GB0223038D0 (en) * | 2002-10-04 | 2002-11-13 | Merck Sharp & Dohme | Therapeutic compounds |
| DE602004002567T2 (de) | 2003-02-17 | 2007-05-31 | F. Hoffmann-La Roche Ag | Piperidinbenzolsulfonamidderivate |
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| US7067509B2 (en) * | 2003-03-07 | 2006-06-27 | Neurocrine Biosciences, Inc. | Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
| EP1640366A4 (en) | 2003-06-30 | 2009-05-13 | Daiichi Seiyaku Co | HETEROCYCLES METHYLSULFON DERIVATIVE |
| MXPA06001559A (es) | 2003-08-08 | 2006-05-15 | Schering Corp | Inhibidores de amina ciclica bace-1 que poseen una benzamida como sustituyente. |
| CA2534672A1 (en) | 2003-08-08 | 2005-02-17 | Schering Corporation | Cyclic amine bace-1 inhibitors having a heterocyclic substituent |
| CA2544350A1 (en) * | 2003-10-29 | 2005-05-12 | Elan Pharmaceuticals, Inc. | N-substituted benzene sulfonamides |
| JP2007526455A (ja) * | 2004-02-03 | 2007-09-13 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 癌を特徴付ける、制御する、診断する、および処置するための組成物ならびに方法 |
| EP2369014A1 (en) | 2004-02-03 | 2011-09-28 | The Regents Of The University Of Michigan Office Of Technology Transfer | Compositions and methods for characterizing, regulating, diagnosing and treating cancer |
| JP2007531742A (ja) * | 2004-04-05 | 2007-11-08 | シェーリング コーポレイション | 新規のγセクレターゼインヒビター |
| AU2005257904A1 (en) * | 2004-06-15 | 2006-01-05 | Merck Sharp & Dohme Corp. | Pyrrolidin-3-yl compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease |
| EP1789404B1 (en) * | 2004-06-30 | 2010-03-24 | Schering Corporation | Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors |
| EP1781625B1 (en) | 2004-07-22 | 2010-12-15 | Schering Corporation | Substituted amide beta secretase inhibitors |
| TW200630337A (en) | 2004-10-14 | 2006-09-01 | Euro Celtique Sa | Piperidinyl compounds and the use thereof |
| US20060252073A1 (en) * | 2005-04-18 | 2006-11-09 | Regents Of The University Of Michigan | Compositions and methods for the treatment of cancer |
| AU2006308847C1 (en) | 2005-10-31 | 2012-05-10 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for treating and diagnosing cancer |
| US9567396B2 (en) | 2006-03-07 | 2017-02-14 | Evonik Degussa Gmbh | Notch inhibition in the prevention of vein graft failure |
| WO2007103114A2 (en) * | 2006-03-07 | 2007-09-13 | The Brigham & Women's Hospital, Inc. | Notch inhibition in the treatment or prevention of atherosclerosis |
| WO2007110449A1 (en) | 2006-03-29 | 2007-10-04 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use |
| WO2007118854A1 (en) | 2006-04-13 | 2007-10-25 | Euro-Celtique S.A. | Benzenesulfonamide compounds and the use thereof |
| WO2007118853A1 (en) | 2006-04-13 | 2007-10-25 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use as blockers of calcium channels |
| US20100226922A1 (en) * | 2006-06-08 | 2010-09-09 | Dorothea Maetzel | Specific protease inhibitors and their use in cancer therapy |
| WO2008055924A1 (en) | 2006-11-07 | 2008-05-15 | Vib Vzw | Diagnosis and treatment of t-cell acute lymphoblastic leukemia |
| JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体 |
| WO2008065141A1 (en) | 2006-11-30 | 2008-06-05 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
| WO2008092002A2 (en) | 2007-01-24 | 2008-07-31 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing pancreatic cancer |
| ZA200905537B (en) | 2007-03-01 | 2010-10-27 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
| US8399486B2 (en) * | 2007-04-09 | 2013-03-19 | Purdue Pharma L.P. | Benzenesulfonyl compounds and the use thereof |
| US9656991B2 (en) | 2007-04-18 | 2017-05-23 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| EP1997805A1 (en) * | 2007-06-01 | 2008-12-03 | Commissariat à l'Energie Atomique | Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans |
| WO2009040659A2 (en) | 2007-09-28 | 2009-04-02 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
| WO2009051661A2 (en) * | 2007-10-12 | 2009-04-23 | The Brigham And Women's Hospital, Inc. | Substituted aryl alkylamino-oxy-analogs and uses thereof |
| WO2011009064A1 (en) * | 2009-07-17 | 2011-01-20 | The J. David Gladstone Institutes | Methods of controlling cell proliferation |
| AU2010276215A1 (en) * | 2009-07-21 | 2012-02-16 | Auckland Uniservices Limited | Heteroaryl benzamides, compositions and methods of use |
| EP2475428B1 (en) | 2009-09-11 | 2015-07-01 | Probiodrug AG | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
| EP2493497A4 (en) | 2009-11-01 | 2013-07-24 | Brigham & Womens Hospital | NOTCH INHIBITION IN THE TREATMENT AND PROPHYLAXIS OF ADIPOSITAS AND METABOLISM SYNDROME |
| JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
| NZ602312A (en) | 2010-03-10 | 2014-02-28 | Probiodrug Ag | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
| JP6050264B2 (ja) | 2011-03-16 | 2016-12-21 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
| WO2013059302A1 (en) | 2011-10-17 | 2013-04-25 | Nationwide Children's Hospital, Inc. | Products and methods for aortic abdominal aneurysm |
| WO2016059220A1 (en) | 2014-10-16 | 2016-04-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Tcr-activating agents for use in the treatment of t-all |
| WO2017023999A1 (en) * | 2015-08-03 | 2017-02-09 | Emory University | Methylsulfonamide derivatives and uses related thereto |
| DK3461819T3 (da) | 2017-09-29 | 2020-08-10 | Probiodrug Ag | Inhibitorer af glutaminylcyklase |
| EP3823672A1 (en) | 2018-07-19 | 2021-05-26 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Combination for treating cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5646167A (en) * | 1993-01-06 | 1997-07-08 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamix acids |
| US5559128A (en) * | 1995-04-18 | 1996-09-24 | Merck & Co., Inc. | 3-substituted piperidines promote release of growth hormone |
| AU773273B2 (en) * | 1999-02-26 | 2004-05-20 | Bristol-Myers Squibb Company | Novel sulfonamide compounds and uses thereof |
| FR2802206B1 (fr) * | 1999-12-14 | 2005-04-22 | Sod Conseils Rech Applic | Derives de 4-aminopiperidine et leur utilisation en tant que medicament |
| CA2406652A1 (en) * | 2000-04-20 | 2001-11-01 | Nps Allelix Corp. | Aminopiperidines for use as glyt-1 inhibitors |
| HUP0303360A2 (hu) * | 2000-09-25 | 2004-01-28 | Actelion Pharmaceuticals Ltd. | Maláriaellenes hatású szubsztituált amino-aza-cikloalkánok és ezeket tartalmazó gyógyszerkészítmények |
| EP1411944A1 (en) * | 2001-08-03 | 2004-04-28 | Schering Corporation | Sulfonamide derivatives as gamma secretase inhibitors |
-
2002
- 2002-08-01 EP EP02761207A patent/EP1411944A1/en not_active Withdrawn
- 2002-08-01 JP JP2003518536A patent/JP2005504042A/ja active Pending
- 2002-08-01 CA CA002455861A patent/CA2455861A1/en not_active Abandoned
- 2002-08-01 US US10/210,803 patent/US7122675B2/en not_active Expired - Fee Related
- 2002-08-01 CN CNA028193520A patent/CN1780621A/zh active Pending
- 2002-08-01 AR ARP020102925A patent/AR035260A1/es unknown
- 2002-08-01 MX MXPA04001016A patent/MXPA04001016A/es unknown
- 2002-08-01 WO PCT/US2002/024293 patent/WO2003013527A1/en not_active Ceased
-
2005
- 2005-09-09 US US11/223,545 patent/US20060009467A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005504042A5 (cg-RX-API-DMAC7.html) | ||
| RU2404189C9 (ru) | Новые пептиды как ингибиторы ns3-серинпротеазы вируса гепатита c | |
| RU2004106540A (ru) | Новые ингибиторы гамма-секретазы | |
| JP2004504404A5 (cg-RX-API-DMAC7.html) | ||
| JP2005515255A5 (cg-RX-API-DMAC7.html) | ||
| SE0104332D0 (sv) | Therapeutic agents | |
| RU2002123350A (ru) | Дипептиднитрильные ингибиторы катепсина К | |
| JP2005539088A5 (cg-RX-API-DMAC7.html) | ||
| CA2410662A1 (en) | Novel peptides as ns3-serine protease inhibitors of hepatitis c virus | |
| JP2006500394A5 (cg-RX-API-DMAC7.html) | ||
| JP2013544812A5 (cg-RX-API-DMAC7.html) | ||
| RU2011103741A (ru) | Композиции и способы лечения заболевания сетчатки | |
| JP2006509015A5 (cg-RX-API-DMAC7.html) | ||
| RU2005110061A (ru) | Замещенные пиперазины, (1,4)-диазепины и 2,5-диазабицикло(2,2,1)гептаны в качестве н1-и/или н3-антагонистов гистамина или обратных н3-антагонистов гистамина | |
| EP2311851A3 (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | |
| JP2005519083A5 (cg-RX-API-DMAC7.html) | ||
| JP2008510828A5 (cg-RX-API-DMAC7.html) | ||
| JP2011509309A5 (cg-RX-API-DMAC7.html) | ||
| RU2012146986A (ru) | Цефемовые соединения, содержащие катехольную группу | |
| CA2431952A1 (en) | Muscarinic antagonists | |
| JP2006502119A5 (cg-RX-API-DMAC7.html) | ||
| JP2007509057A5 (cg-RX-API-DMAC7.html) | ||
| CA2281426A1 (en) | Substituted indole compounds as anti-inflammatory and analgesic agents | |
| JP2006507355A5 (cg-RX-API-DMAC7.html) | ||
| JP2005538111A5 (cg-RX-API-DMAC7.html) |